ATE522228T1 - Verwendung einer hilfsstoffhaltigen impfstoffformulierung für subkutane verabreichung - Google Patents

Verwendung einer hilfsstoffhaltigen impfstoffformulierung für subkutane verabreichung

Info

Publication number
ATE522228T1
ATE522228T1 AT07105094T AT07105094T ATE522228T1 AT E522228 T1 ATE522228 T1 AT E522228T1 AT 07105094 T AT07105094 T AT 07105094T AT 07105094 T AT07105094 T AT 07105094T AT E522228 T1 ATE522228 T1 AT E522228T1
Authority
AT
Austria
Prior art keywords
vaccine formulation
excipient
subcutaneous administration
containing vaccine
allergen
Prior art date
Application number
AT07105094T
Other languages
English (en)
Inventor
Eike Gunther Wuestenberg
Original Assignee
Alk Abello As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38093538&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE522228(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alk Abello As filed Critical Alk Abello As
Application granted granted Critical
Publication of ATE522228T1 publication Critical patent/ATE522228T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
AT07105094T 2007-03-28 2007-03-28 Verwendung einer hilfsstoffhaltigen impfstoffformulierung für subkutane verabreichung ATE522228T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07105094A EP1974745B1 (de) 2007-03-28 2007-03-28 Verwendung einer hilfsstoffhaltigen Impfstoffformulierung für subkutane Verabreichung

Publications (1)

Publication Number Publication Date
ATE522228T1 true ATE522228T1 (de) 2011-09-15

Family

ID=38093538

Family Applications (2)

Application Number Title Priority Date Filing Date
AT07105094T ATE522228T1 (de) 2007-03-28 2007-03-28 Verwendung einer hilfsstoffhaltigen impfstoffformulierung für subkutane verabreichung
AT08153545T ATE540691T1 (de) 2007-03-28 2008-03-28 Verwendung einer hilfsstoffhaltigen impfstoffformulierung für parenterale verabreichung

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT08153545T ATE540691T1 (de) 2007-03-28 2008-03-28 Verwendung einer hilfsstoffhaltigen impfstoffformulierung für parenterale verabreichung

Country Status (5)

Country Link
US (1) US20120141536A1 (de)
EP (1) EP1974745B1 (de)
AT (2) ATE522228T1 (de)
DK (2) DK1974745T3 (de)
ES (2) ES2370043T3 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2908857B1 (de) * 2012-10-19 2017-08-09 Hal Allergy Holding B.V. Zusammensetzungen zur immuntherapie

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4031199A (en) 1972-12-11 1977-06-21 Merck Patent Gesellschaft Mit Beschrankter Haftung Process for the production of allergen-containing extracts
CA2554337A1 (en) * 2004-02-06 2005-08-25 Greer Laboratories, Inc. Methods and compositions for dosing of allergens
CA2556557A1 (en) 2004-02-26 2005-09-09 Alk Abello A/S Method of evaluating the therapeutic potential of a vaccine for mucosal administration
US20060115499A1 (en) * 2004-09-27 2006-06-01 Alk-Abello A/S Liquid allergy vaccine formulation for oromucosal administration

Also Published As

Publication number Publication date
ATE540691T1 (de) 2012-01-15
EP1974745A1 (de) 2008-10-01
EP1974745B1 (de) 2011-08-31
DK1974745T3 (da) 2011-11-28
ES2380172T3 (es) 2012-05-09
US20120141536A1 (en) 2012-06-07
ES2370043T3 (es) 2011-12-12
DK1974746T3 (da) 2012-04-10

Similar Documents

Publication Publication Date Title
CO6670520A2 (es) Lactmas sustituidas con piperidinio como moduladores de gpr119
BR112013029256A8 (pt) combinação farmacêutica para uso no tratamento de pacientes com diabetes tipo 2
MX366314B (es) Uso de derivados de insulina por inyecciones con intervalos variables.
BR112012027759A2 (pt) Conjugados de peptídeos de agonistas de receptores glp-1 e gastrina e seu uso
EP3153198C0 (de) Medizinischer injektor mit stiftnadelbaugruppe
NZ718622A (en) Multisubstituted aromatic compounds as inhibitors of thrombin
EA201201657A1 (ru) Лечение диабета
UA117570C2 (uk) Спосіб лікування діабету або діабету, спричиненого ожирінням, або ускладнень при діабеті
EA201100335A1 (ru) Производные пурина для применения при лечении связанных с fab заболеваний
MX366405B (es) Uso de peptidos glp-1 de accion prolongada.
SMT201500190B (it) Composizioni comprendenti un anticorpo a p2-specifico o un suo frammento per l'uso nel trattamento del diabete, intolleranza al glucosio o insulino-resistenza indotta dall'obesita'
CO6501147A2 (es) Inhibidores de mtor cinasa para indicadores de oncología y enfermedades asociadas con la trayectoria mtor/pi3k/akt
BR112014010590A2 (pt) 18-metil-6,7-metilen-3-oxo-17-pregn-4-eno-21,17?-carbolactonas, preparações farmacêuticas contendo os compostos mencionados e seu uso na terapia da endometriose
BRPI0919946A2 (pt) tratamento de diabetes melito usando injeções de insulina com frequência de injeção menor que diariamente
MX377157B (es) Preparación para usarse en el tratamiento de un cáncer positivo de gd2.
NZ719520A (en) Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated braf pathway
BR112012027197A2 (pt) combinação ou composição farmacêutica, seu uso, kit, e compostos para tratamento de doenças oncológicas e fibróticas
MX2013011175A (es) Analogos de glucagon novedosos.
UA113849C2 (xx) Застосування сигма-лігандів при болю, пов'язаному з діабетом 2 типу
EA201491702A1 (ru) Оптимизированные терапевтические агенты для подкожного введения
BR112012030482A2 (pt) tratamento de diabetes tipo 2
ATE522228T1 (de) Verwendung einer hilfsstoffhaltigen impfstoffformulierung für subkutane verabreichung
BR112013010345A2 (pt) tratamento de diabetes melitus usando as injeções de insulina administradas com intervalos de variação da injeção
UY31646A1 (es) Uso de fenilimidazolidinas sustituidas para producir medicamentos para el tratamiento del síndrome metabólico
CY1111534T1 (el) Χρηση αλατων τιοτροπιου στην αντιμετωπιση μετριου επιμονου ασθματος

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties